About Lymphoma Hub
Steered by world leaders in Lymphoma and CLL, the Lymphoma Hub provides the latest treatment options, medical information, case studies, recommendations, and expert opinions. The lymphoma Hub supports community hematologists and oncologists in making informed treatment decisions and ensuring patients have access to the latest therapies available.
Our mission is to provide up‑to-date, practical, clinical advice to community hematologists and oncologists seeking treatment options for lymphoma and CLL, to improve the lives of patients.
The Lymphoma Hub is published by PHASE II International (company registration number 3386788). The registered office is situated at Pharmawork House, 3 AC Court, High Street, Thames Ditton, Surrey, KT7 0SR, UK.
You can get in touch with us through our social media channels below:
The Executive Steering Committee sets the vision of the Lymphoma Hub, leading the content and direction of each subtype.
The Scientific Advisory Board works alongside the Executive Steering Committee providing expert opinions and insights into the latest clinical data
The Innovation Committee translates clinical breakthroughs into the context of everyday clinical practice
The Secretariat take care of the everyday management and uploads on the Lymphoma Hub.